Cholangiocarcinoma of the extrahepatic bile ducts

Seminars in Surgical Oncology

Volumn 19, Issue 2, 2000, Pages 156-176

  Jarnagin, William R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adenocarcinoma; Bile duct neoplasms; Cholangiocarcinoma; Differential diagnosis; Endoscopic retrograde cholangiopancreatography; Extrahepatic bile ducts; Magnetic resonance imaging; Neoplasm staging; Palliative care

Indexed keywords

FLUOROURACIL; PACLITAXEL; RECOMBINANT ALPHA2B INTERFERON;

ARTICLE; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SURVIVAL; CHOLANGIOGRAPHY; CLINICAL TRIAL; DRUG EFFICACY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURGICAL ANATOMY; SURGICAL TECHNIQUE;

EID: 0033777650     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2388(200009)19:2<156::aid-ssu8>3.0.co;2-%23     Document Type: Article

References (135)

1. Hilar cholangiocarcinoma: Patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system
2. Outcome of treatment for distal bile duct cancer
3. Immune responsiveness and parasite-specific antibody levels in human hepatobiliary disease associated with Opisthorchis viverrini infection
4. Spontaneous cutaneous biliary fistula: A rare complication of cholangiocarcinoma
5. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors
6. Prognostic factors in bile duct carcinoma. Analysis of 96 cases
7. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications, and outcomes
8. Outcomes after curative resections of cholangiocarcinoma
9. A western surgical experience of peripheral cholangiocarcinoma
10. Intrahepatic cholangiocarcinoma
11. Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma
12. Lymphomatous involvement of intrahepatic and extrahepatic biliary ducts. PTC and ERCP findings
13. Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors
14. Diffuse bile duct tumors: Guidelines for management
15. Carcinoma of the major intrahepatic and extrahepatic bile ducts exclusive of the papilla of Vater
16. Liver, gallbladder, intrahepatic bile ducts, and pancreas
17. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma. A study of 57 autopsy proven cases
18. Carcinoma of the extrahepatic bile ducts: Review of the literature and report of six cases
19. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis
20. Character of a human cholangiocarcinoma CHGS, serially transplanted to nude mice
21. Malignancies of the biliary tree
22. Choledochal cyst in pregnancy: A therapeutic dilemma
23. Current management of cholangiocarcinoma
24. Choledochal cyst disease. A changing pattern of presentation
25. Biliary tract cancer accompanied by anomalous junction of pancreaticobiliary ductal system in adults
26. Coexisting sharp ductal angulation with intrahepatic biliary strictures in right hepatolithiasis
27. Late development of bile duct cancer after sphincteroplasty: A ten- to twenty-two-year follow-up study
28. Malignancy associated with hepatolithiasis
29. Hepatolithiasis associated with cholangiocarcinoma
30. Serum PAF-acetylhydrolase in severe renal or hepatic disease in man: Relationship to circulating levels of PAF and effects of nephrectomy or transplantation
31. Diffuse increase in renal uptake of technetium 99m methylene diphosphonate in association with disseminated cholangiocarcinoma
32. Cholangiocarcinoma in patients with opisthorchiasis
33. Sclerosing carcinoma of the intrahepatic (hilar) bile ducts
34. Adenocarcinoma of the hepatic duct at its bifurcation within the prota hepatis
35. Surgical treatment of adenocarcinoma. Location: Junction of the right, left, and common hepatic ducts
36. Carcinoma of the bifurcation of the hepatic ducts
37. Pathological aspects of cholangiocarcinoma
38. The infiltration of bile duct carcinoma along the bile duct wall
39. Carcinoma of the extrahepatic bile ducts
40. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma
41. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique
42. Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholangiocarcinomas from paraffin-embedded tissue sections
43. Combined use of surgical treatment and postoperative radiotherapy for carcinoma of the intrahepatic bile ducts
44. Carcinoid tumor of the biliary system. Case report and literature review
45. Primary carcinoid tumor of the cystic and common bile ducts
46. Carcinoid tumors of the intrahepatic bile duct: An unusual cause of bile duct obstruction
47. 'Natural history' of unresected cholangiocarcinoma: Patient outcome after noncurative intervention
48. Cholangiocarcinoma in northeast Thailand
49. Biliary tract
50. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma
51. Pre-operative percutaneous transhepatic biliary drainage: The results of a controlled trial
52. Malignant masquerade at the hilum of the liver
53. Carcinoma of the proximal extrahepatic biliary tree radiologic assessment and therapeutic alternatives
54. Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors)
55. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survivak
56. Bile duct obstruction: Radiologic evaluation of level, cause and tumor resectability
57. Cholangiocarcinoma at the hepatic hilus: Sonographic findings
58. The role of ultrasound, percutaneous transhepatic cholangiography, computed tomographic scanning, and magnetic resonance imaging in the preoperative assessment of bile duct cancer
59. Portal vein evaluation with US: Comparison to angiography combined with CT arterial portography
60. Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging
61. MR imaging of hilar cholangiocarcinoma - Comparative study with CT
62. Extrahepatic biliary diseases: 3D MR cholangiopancreatography compared with endoscopic retrograde cholangiopancreatography
63. Neoplastic pancreaticobiliary duct obstruction: Evaluation with breath-hold MR cholangiopancreatography
64. A preoperative biliary stent is associated with increased complications after pancreatocuodenectomy
65. Management of the Mirizzi syndrome and the surgical implications of cholecystocholedochal fistula
66. Mirizzi syndrome
67. Staging laparoscopy with laparoscopic ultrasonography: Optimizing resectability in hepatobiliary and pancreatic malignancy
68. Resection of hilar cholangiocarcinoma - A European and United States experience
69. Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors
70. Integrins: Utility as cell-type and stage-specific markers for hepatocellular carcinoma and cholangiocarcinoma
71. Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: A study in 65 patients with bile duct strictures
72. Role of liver atrophy, hepatic resection and hepatocyte hyperplasia in the development of portal hypertension in biliary disease
73. Tumor involvement in hepatic veins: Comparison of MR imaging and US for preoperative assessment
74. Management strategies in resection for hilar cholangiocarcinoma
75. Staging of biliary carcinoma: Cholangiography and cholangioscopy
76. Technique of inserting multiple biliary drains and management
77. Resectional surgery of hilar cholangiocarcinoma: A multivariate analysis of prognostic factors
78. Surgical treatment in proximal bile duct cancer. A single-center experience
79. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation
80. Role of liver transplantation in the treatment of unresectable liver cancer
81. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus
82. Surgical anatomy of the hepatic hilum with special reference to the caudate lobe
83. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report
84. Preoperative portal vein embolization for hepatocellular carcinoma
85. Portal vein embolization: Utility for inducing left hepatic lobe hypertrophy before surgery
86. Radical operation after portal embolization for tumor of hilar bile duct
87. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization
88. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma
89. Hepaticojejunostomy in benign and malignant high bile duct stricture: Approaches to the left hepatic ducts
90. Combined portal vein and liver resection for carcinoma of the biliary tract
91. Primary sclerosing cholangitis
92. Arterial reconstruction of the posterior segment after central bisegmentectomy and caudate lobectomy
93. Segments I and IV resection as a new approach for hepatic hilar cholangiocarcinoma
94. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy
95. Proximal bile duct cancer. Quality of survival
96. One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique
97. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: Blood loss, blood transfusion, and the risk of postoperative renal dysfunction
98. Surgical treatment of hilar carcinoma of the bile duct
99. A technique for the construction of high biliary-enteric anastomoses
100. Outcome of radical surgery in hilar cholangiocarcinoma
101. The CT and US aspects in hepatic cholangiocarcinoma due to thorium dioxide (thorotrast). A case report and review of the literature
102. Is liver transplantation justified for the treatment of hepatic malignancies?
103. Radiofrequency thermotherapy for malignant liver tumors
104. Cholangiocarcinoma complicating primary sclerosing cholangitis
105. Improvements in survival by aggressive resections of hilar cholangiocarcinoma
106. What constitutes long-term survival after surgery for hilar cholangiocarcinoma?
107. Surgical strategy for the management of hilar bile duct cancer
108. Primary sclerosing cholangitis: Resect, dilate or transplant?
109. The role of radiotherapy in the management of extrahepatic bile duct cancer: An analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy
110. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma
111. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy
112. Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors
113. Percutaneous palliation of malignant obstructive jaundice with the Wallstent endoprosthesis: Follow-up and reintervention in patients with hilar and non-hilar obstruction
114. Endoscopic stenting for malignant biliary obstruction
115. Biliary Wallstent endoprosthesis in malignant hilar obstruction: Long-term results with regard to the type of obstruction
116. Unresectable malignant biliary obstruction: Treatment by self-expandable biliary endoprostheses
117. Complications of percutaneously inserted biliary Wallstents
118. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: A case-control study
119. Immunohistochemistry in the differential diagnosis of liver carcinomas
120. Metallic stems in malignant biliary obstruction: Results of a multicenter European study of 240 patients
121. Intrahepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence
122. Effect of communication between the right and left liver on the outcome of surgical drainage for jaundice due to malignant obstruction at the hilus of the liver
123. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in nonresectable cholangiocarcinoma
124. Intraarterial and intraportal chemotherapy combined with decollateralization for cholangiocellular carcinoma and metastatic liver cancer
125. External beam and intraluminal radiotherapy for locally advanced bile duct cancer: Role and tolerability
126. Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer
127. Photodynamic therapy of nonresectable cholangiocarcinoma
128. Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas
129. Experience with distal bile duct cancers in the U.S. Veterans Affairs hospitals: 1987-1991
130. Periampullary tumours: Which ones should be resected?
131. Comparison of magnetic resonance and endoscopic retrograde cholangiopancreatography in malignant pancreaticobiliary obstruction
132. Cytologic brushings of ductal lesions during ERCP
133. Guidelines for the application of surgery and endoprostheses in the palliation of obstructive jaundice in advanced cancer of the pancreas
134. Cancer of the bile ducts: The hepatic duct and the common bile duct